[Focus on health surveillance of health workers exposed to blood-transmissible biological agents: results and perspectives of a multicenter working group].
The biological risk from exposure to bloodborne pathogens in health care environments represents a frequent and widespread risk, involving a large number of exposed workers. On the basis of the available scientific innovations, the recent legislation regarding health and safety of workers and the experiences of SIMLII guidelines on health surveillance (HS) workers exposed to biological risk, a multicenter study was carried out, involving nine relevant hospitals and about 32 000 healthcare workers (HCW). A review of the literature was performed, with particular reference to the last 10 years. For each hospital, protocols of HS have been examined according to tasks and biological risk from bloodborne viruses (HBV, HDV, HCV, HIV) as well as management of HCW infected with this pathogens. Differences of risk management in the hospitals, in relationship also with recommendations of the literature have been evaluated. The literature supplies important indications for HS management of HCW exposed to bloodborne pathogens, with relevant information also for patient safety. Preventive examinations are in line with the recommendations of literature and similar across the hospitals for HCV and HIV, while they are different for HBV. Periodic surveillance was different for the frequency, among the hospitals and also as compared to national SIMLII guidelines. As for management, no differentiation among the hospitals was detected as referred to different risk of exposure, while differences were observed around definitions of restrictions. Finally, good medical practices to support occupational physicians in the prevention and management of HCWs' exposed to biological risks are suggested.
Dip. Medicina del Lavoro, Sez. Ospedale Sacco, Università degli Studi di Milano, Italy.
P
P
Carrer
G
G
Micheloni
M
M
Campagna
M
M
Bacis
L
L
Belotti
N
N
Biggi
L
L
Cologni
V
V
Gattini
J
J
Fostinelli
V
V
Lodi
N
N
Magnavita
C
C
Negro
E
E
Omeri
D
D
Placidi
R
R
Polato
V
V
Puro
F
F
Tonelli
S
S
Porru
D001688:Biological Products / Q000009:adverse effects*; D017848:Blood-Borne Pathogens; D003141:Communicable Diseases / Q000382:microbiology*; D006282:Health Personnel; D006801:Humans; D009784:Occupational Diseases / Q000382:microbiology* / Q000517:prevention & control*; D016273:Occupational Exposure
D001688:Biological Products